InvestorsHub Logo
Followers 2
Posts 1472
Boards Moderated 0
Alias Born 07/20/2016

Re: None

Sunday, 09/30/2018 1:25:16 PM

Sunday, September 30, 2018 1:25:16 PM

Post# of 108192
https://www.precisionvaccinations.com/isa-pharmaceuticals-vaccine-isa101-combined-bms-nivolumab-demonstrated-safety-and-efficacy-resulting?s=en&utm_source=newsletter&utm_campaign=pv-consumer-general&utm_medium=email&utm_content=[%20_currentdayname]

HPV-16 is one of the targets of AXAL. Advaxis was going to combine it with nivolumad as ADXS-DUAL. That could have been our name in that article. Another missed opportunity?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News